Former Georgia CTSA KL2 Scholar Leads Clinical Arm at Emory on Joint $2.8M NIH-Funded Epilepsy Study
“Our goal is to stop seizures at their earliest stages, ideally before they have a chance to spread,” says Ezequiel Gleichgerrcht, MD, PhD, Emory. “By applying advanced brain network modeling to real-world patient data, we aim to translate this technology from animal models into a device that could transform care for people living with drug-resistant epilepsy.” Gleichgerrcht is a former Georgia CTSA KL2 Scholar and CPTS graduate.